COVID-19 has put pharma back in the spotlight – giving birth to and boosting an eclectic mix of key trends and consumer behaviours.
Twelve months on from our first taste of curfew, the transformation in our daily lives could scarcely have been predicted. But transformation has occurred, and will continue to occur, as we navigate the other side of the pandemic. Our evolving relationship with healthcare will be at the centre of this, underpinned by distinctly COVID-ready trends. Here we outline a selection of them.